Mylan Inc.
NASDAQ: MYL
$15.86
+$0.00 (+0.0%)
Closing Price on November 19, 2020
MYL Articles
Short sellers piled on to Apple again between the November 13 and November 30 settlement dates, lifting its short interest to a year-to-date high.
Published:
Last Updated:
Mylan announced Monday that it would be conducting a share repurchase for up to $1 billion, in a much faster timeline for repurchasing than most companies would give.
Published:
Last Updated:
Between the October 15 and October 30 settlement dates, short interest declined in many of the most heavily shorted stocks traded on the Nasdaq.
Published:
Last Updated:
Mylan reported better-than-expected third-quarter financial results before the markets opened on Friday.
Published:
Last Updated:
Mylan is scheduled to release its third-quarter financial results before the markets open on Friday.
Published:
Martin Shkreli has said he would lower the price of Daraprim back down but hasn’t actually done it. He probably figures that if he can outlast the initial wave of negative publicity, people will...
Published:
Mylan announced Tuesday, in conjunction with the Irish Takeover Panel, that Perrigo had made misleading statements to shareholders.
Published:
ThinkstockWith biotech and specialty pharmaceutical stocks, catalysts and binary events can drive the stocks much higher, or in some cases much lower if the outcome is not what Wall Street was...
Published:
It may be impossible to ever know if a true bottom has ever been seen, but many investors love finding great companies where they feel that a sell-off has overly punished the share price.
Published:
A new research report from UBS makes an interesting switch in the Quality Growth At a Reasonable Price (Q-GARP) portfolio.
Published:
Last Updated:
ThinkstockMylan N.V. (NASDAQ: MYL) is considered a serious value play in the health care sector by a key analyst. Argus has a Buy rating for the company but reduced its price target to $65, from $85....
Published:
Last Updated:
Friday's top analyst upgrades, downgrades and initiations include BankUnited, Barrick Gold, ConocoPhillips, Michael Kors, Mylan, Viacom and Disney.
Published:
Frank Golhen, via Wikimedia Commons24/7 Wall St. has put together a preview of some of the major companies reporting their quarterly results this week. We have included the consensus earnings...
Published:
Last Updated:
ThinkstockTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) may have just proved how financially fit and capable the company is. On Friday afternoon the global generic drug giant reported that it has...
Published:
Teva could be about to enter the largest generic market by prescription in the world, which may tip the scales in its favor when it comes to wooing Mylan shareholders.
Published: